GSK Highlights E-Commerce Gains As Sales Growth Returns
Executive Summary
GSK is continuing to invest in e-commerce and sees opportunities for online growth in its "underdeveloped" dietary supplements category. Better e-commerce sales helped to drive up GSK Consumer Healthcare's Q2 turnover by 7% at constant currencies.
You may also be interested in...
GSK Consumer Split Set For July, With Emerging Markets And Switch To Drive Growth
GSK will spin-off its consumer health business in July under the name Haleon. The standalone operation expects to outpace market growth rates by expanding in emerging markets, tapping into consumer demand for more natural products and delivering two Rx-to-OTC switches in the US.
Euro Q3 Consumer Health Earnings Preview: GSK, Sanofi, Bayer And Reckitt
Major Europe-based consumer health players GSK, Sanofi, Bayer and Reckitt continue to deal with the fallout of the COVID-19 pandemic while implementing long-term strategies to drive growth. This earnings preview highlights what to look out for as these four firms report their third-quarter results over the coming weeks.
Bayer Spreads Aleve Brand Into Topical Pain Relief
Three-product AleveX line contains menthol and camphor for minor muscle and joints aches and pains with a cooling sensation. Bayer Healthcare promotes launch with an ad campaign featuring basketball legend and TV personality Charles Barkley.